Mather Group, Llc. Bio Rad Laboratories, Inc. Transaction History

Mather Group, Llc.

$7.74 Billion
Q3 2024

A detailed history of Mather Group, Llc. transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 169 shares of BIO stock, worth $55,342. This represents 0.0% of its overall portfolio holdings.

Number of Shares

169

Previous 360 53.06%

Holding current value

$55,342

Previous $98,000 42.86%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$263.97 - $344.64 $50,418 - $65,826	-191 Reduced 53.06%	169 $56,000
Q2 2024 Jul 08, 2024	BUY	$268.26 - $339.48 $26,826 - $33,948	100 Added 38.46%	360 $98,000
Q1 2024 Apr 08, 2024	BUY	$304.11 - $351.99 $79,068 - $91,517	260 New	260 $89,000
Q1 2023 May 09, 2023	BUY	$418.69 - $503.0 $1,256 - $1,509	3 Added 0.58%	520 $249,000
Q4 2022 Mar 10, 2023	BUY	$351.71 - $456.01 $181,834 - $235,757	517 New	517 $217,000
Q2 2022 Aug 16, 2022	BUY	$463.67 - $597.16 $20,401 - $26,275	44 Added 11.67%	421 $208,000
Q1 2022 May 13, 2022	BUY	$524.57 - $735.42 $12,589 - $17,650	24 Added 6.8%	377 $212,000
Q4 2021 Feb 15, 2022	SELL	$708.84 - $794.68 $10,632 - $11,920	-15 Reduced 4.08%	353 $267,000
Q3 2021 Nov 04, 2021	SELL	$657.71 - $825.77 $13,154 - $16,515	-20 Reduced 5.15%	368 $275,000
Q2 2021 Aug 13, 2021	SELL	$576.64 - $649.04 $2,883 - $3,245	-5 Reduced 1.27%	388 $250,000
Q1 2021 May 14, 2021	BUY	$547.01 - $662.35 $547 - $662	1 Added 0.26%	393 $224,000
Q4 2020 Feb 12, 2021	BUY	$510.68 - $643.45 $1,532 - $1,930	3 Added 0.77%	392 $229,000
Q3 2020 Nov 13, 2020	BUY	$454.43 - $535.6 $176,773 - $208,348	389 New	389 $201,000

Others Institutions Holding BIO

# of Institutions

456

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.07B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.

Account